Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220962967> ?p ?o ?g. }
- W4220962967 endingPage "4480" @default.
- W4220962967 startingPage "4457" @default.
- W4220962967 abstract "Recent mouse knockout studies identified adapter protein-2 associated kinase 1 (AAK1) as a viable target for treating neuropathic pain. Potent small-molecule inhibitors of AAK1 have been identified and show efficacy in various rodent pain models. (S)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211) (34) was identified as a highly selective, CNS penetrant, potent AAK1 inhibitor from a novel class of bi(hetero)aryl ethers. BMS-986176/LX9211 (34) showed excellent efficacy in two rodent neuropathic pain models and excellent central nervous system (CNS) penetration and target engagement at the spinal cord with an average brain to plasma ratio of 20 in rat. The compound exhibited favorable physicochemical and pharmacokinetic properties, had an acceptable preclinical toxicity profile, and was chosen for clinical trials. BMS-986176/LX9211 (34) completed phase I trials with good human pharmacokinetics and minimum adverse events and is currently in phase II clinical trials for diabetic peripheral neuropathic pain (ClinicalTrials.gov identifier: NCT04455633) and postherpetic neuralgia (ClinicalTrials.gov identifier: NCT04662281)." @default.
- W4220962967 created "2022-04-03" @default.
- W4220962967 creator A5002083359 @default.
- W4220962967 creator A5002306266 @default.
- W4220962967 creator A5003758876 @default.
- W4220962967 creator A5004779066 @default.
- W4220962967 creator A5006669405 @default.
- W4220962967 creator A5009803601 @default.
- W4220962967 creator A5010145000 @default.
- W4220962967 creator A5011206066 @default.
- W4220962967 creator A5013220640 @default.
- W4220962967 creator A5018056025 @default.
- W4220962967 creator A5019236230 @default.
- W4220962967 creator A5020195400 @default.
- W4220962967 creator A5020517616 @default.
- W4220962967 creator A5021884590 @default.
- W4220962967 creator A5022585628 @default.
- W4220962967 creator A5023575873 @default.
- W4220962967 creator A5024957034 @default.
- W4220962967 creator A5025904200 @default.
- W4220962967 creator A5030579706 @default.
- W4220962967 creator A5030640333 @default.
- W4220962967 creator A5033934285 @default.
- W4220962967 creator A5034511241 @default.
- W4220962967 creator A5036118118 @default.
- W4220962967 creator A5036777383 @default.
- W4220962967 creator A5036973283 @default.
- W4220962967 creator A5037543794 @default.
- W4220962967 creator A5039683927 @default.
- W4220962967 creator A5041183323 @default.
- W4220962967 creator A5044356220 @default.
- W4220962967 creator A5045072628 @default.
- W4220962967 creator A5045509901 @default.
- W4220962967 creator A5046157713 @default.
- W4220962967 creator A5047591125 @default.
- W4220962967 creator A5049393312 @default.
- W4220962967 creator A5050258194 @default.
- W4220962967 creator A5051819016 @default.
- W4220962967 creator A5051819303 @default.
- W4220962967 creator A5053275832 @default.
- W4220962967 creator A5057762207 @default.
- W4220962967 creator A5058102521 @default.
- W4220962967 creator A5058152350 @default.
- W4220962967 creator A5063320331 @default.
- W4220962967 creator A5070894857 @default.
- W4220962967 creator A5071063887 @default.
- W4220962967 creator A5071360156 @default.
- W4220962967 creator A5075919164 @default.
- W4220962967 creator A5076134716 @default.
- W4220962967 creator A5077583166 @default.
- W4220962967 creator A5079121392 @default.
- W4220962967 creator A5081370900 @default.
- W4220962967 creator A5081649221 @default.
- W4220962967 creator A5082849902 @default.
- W4220962967 creator A5083294704 @default.
- W4220962967 creator A5086123643 @default.
- W4220962967 creator A5086370517 @default.
- W4220962967 creator A5087075714 @default.
- W4220962967 creator A5087449780 @default.
- W4220962967 creator A5089764461 @default.
- W4220962967 creator A5089945074 @default.
- W4220962967 date "2022-03-08" @default.
- W4220962967 modified "2023-10-18" @default.
- W4220962967 title "Discovery of (<i>S</i>)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain" @default.
- W4220962967 cites W1778785184 @default.
- W4220962967 cites W1826847771 @default.
- W4220962967 cites W1965829294 @default.
- W4220962967 cites W1970125541 @default.
- W4220962967 cites W1971882415 @default.
- W4220962967 cites W1982135531 @default.
- W4220962967 cites W1985069323 @default.
- W4220962967 cites W1985097347 @default.
- W4220962967 cites W1988468531 @default.
- W4220962967 cites W2014007136 @default.
- W4220962967 cites W2018021139 @default.
- W4220962967 cites W2022835494 @default.
- W4220962967 cites W2024106658 @default.
- W4220962967 cites W2025996007 @default.
- W4220962967 cites W2030215451 @default.
- W4220962967 cites W2034921827 @default.
- W4220962967 cites W2036930114 @default.
- W4220962967 cites W2038152406 @default.
- W4220962967 cites W2045437791 @default.
- W4220962967 cites W2050373464 @default.
- W4220962967 cites W2058020736 @default.
- W4220962967 cites W2066253511 @default.
- W4220962967 cites W2069886558 @default.
- W4220962967 cites W2073050255 @default.
- W4220962967 cites W2082209601 @default.
- W4220962967 cites W2100006012 @default.
- W4220962967 cites W2100772783 @default.
- W4220962967 cites W2115372776 @default.
- W4220962967 cites W2118973203 @default.
- W4220962967 cites W2121398326 @default.
- W4220962967 cites W2127894556 @default.
- W4220962967 cites W2139776339 @default.
- W4220962967 cites W2145089843 @default.
- W4220962967 cites W2149599746 @default.